healthy individuals
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Subjects of men and women aged 20 to 64 (2) Subjects who received a sufficient explanation of the purpose and contents of the study, an ability to consent, a volunteer who volunteered to participate with a good understanding and who agreed to participate in the study
Exclusion criteria
Exclusion criteria: (1)Subjects with liver disease, kidney disease, digestive system disease, heart disease, peripheral angiopathy and others who have a medical history that may affect the results of this test, or subjects who have a history of surgery (2)Subjects who show abnormal liver function and kidney function test values (3)Subjects who have a disease currently being treated (4)Subjects who have developed stone disease within the second degree of kinship (5)Subjects with food and drug allergy (6)Subjects taking warfarin (7)Subjects with anemic symptoms (8)Subjects on diet (9)Subjects with irregular lives (10)Subjects who can not quit the intake of health food (including food for FOSHU and Foods with Function Claims') and designated quasi-drugs during the test period (11)Subjects who are taking medication (OTC drugs, including prescription drugs) continuously (12)Subjects taking excessive alcohol (13)Subjects who cannot stop drinking from the day before the test to the day of the test (14)Subjects who are pregnant or who are planning pregnancy or breastfeeding during the study period (15)Subjects participating in or planning to participate in other clinical trials at the start of this study (16)Subjects judged by the investigator as inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fe, Zn, Folic acid, VB1, VA, Alb, TP | — |
Countries
Japan
Contacts
Oneness Support Co., Ltd. Clinical Trial Division